William Lewis - 04 Jan 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ William Lewis
Issuer symbol
NAMS
Transactions as of
04 Jan 2024
Net transactions value
$0
Form type
4
Filing time
08 Jan 2024, 19:43:03 UTC
Previous filing
31 Oct 2023
Next filing
10 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAMS Option (right to buy) Award $0 +100,000 $0.000000 100,000 04 Jan 2024 Ordinary Shares 100,000 $12.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option will vest on January 4, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.